Evaluation of repeat on new curve [Bioanalytics]

posted by swapnil.kuche – 2011-07-05 11:46 (5470 d 11:46 ago) – Posting: # 7210
Views: 3,839

Dear Auditor,

I am totally agree with the Ohlbe. :cool:

While switch over to new calibration range obviously you had perform partial validation. :confused:

If your method is partially validated properly there is no problem to analyse old identified repeats under new calibration curve.

Believe me we had done the same in USFDA submission study and it was accepted by regulators provided that your Repeat Analysis SOP should be very much clear on such issues. ;-)


Regards,
Swapnil D. Kuche

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,570 registered users;
373 visitors (0 registered, 373 guests [including 28 identified bots]).
Forum time: 23:32 CEST (Europe/Vienna)

Ignorance more frequently begets confidence
than does knowledge.    Charles Darwin

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5